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ABSTRACT
....................................................................................................................................................
Objective To describe the goals of the Proteomics Standards Initiative (PSI) of the Human Proteome Organization, the
methods that the PSI has employed to create data standards, the resulting output of the PSI, lessons learned from
the PSI’s evolution, and future directions and synergies for the group.
Materials and Methods The PSI has 5 categories of deliverables that have guided the group. These are minimum infor-
mation guidelines, data formats, controlled vocabularies, resources and software tools, and dissemination activities.
These deliverables are produced via the leadership and working group organization of the initiative, driven by frequent
workshops and ongoing communication within the working groups. Official standards are subjected to a rigorous docu-
ment process that includes several levels of peer review prior to release.
Results We have produced and published minimum information guidelines describing what information should be pro-
vided when making data public, either via public repositories or other means. The PSI has produced a series of standard
formats covering mass spectrometer input, mass spectrometer output, results of informatics analysis (both qualitative
and quantitative analyses), reports of molecular interaction data, and gel electrophoresis analyses. We have produced
controlled vocabularies that ensure that concepts are uniformly annotated in the formats and engaged in extensive soft-
ware development and dissemination efforts so that the standards can efficiently be used by the community.
Conclusion In its first dozen years of operation, the PSI has produced many standards that have accelerated the field of
proteomics by facilitating data exchange and deposition to data repositories. We look to the future to continue develop-
ing standards for new proteomics technologies and workflows and mechanisms for integration with other omics data
types. Our products facilitate the translation of genomics and proteomics findings to clinical and biological phenotypes.
The PSI website can be accessed at http://www.psidev.info.
....................................................................................................................................................
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INTRODUCTION
Mass spectrometry (MS) proteomic identification of the protein
content of clinical samples is of increasing importance in labo-
ratory medicine. MS-based proteomic measurements have
been used in a wide range of biological and biomedical studies,
including the identification and monitoring of markers of dis-
ease onset and progression, toxicology studies, and monitoring
of drug responsiveness. MS proteomics encompasses a broad
range of separation and identification techniques and is per-
formed on many different instrumentation and software plat-
forms. Research in this field therefore needs to be supported
by a robust data analysis pipeline to process the many data
types generated at various stages of the analysis process.
It has been broadly recognized that common data standards
are a crucial element of advancing a research field.1–5 The
many benefits include the enhanced interoperability of software
tools, greater usability of tools across different instrument ven-
dors and computer operating systems, and the increased ease
of sharing, reusing, and depositing data in public repositories.
Minimum information (MI) guidelines describe what data ele-
ments and metadata are to be provided when making data
public, while data formats are the data models for encoding the
information that is to be shared. Formats may be broadly cate-
gorized as ad hoc formats, which are quickly implemented to
meet immediate needs of one group or developer, de facto
standards, which have never been through a standardization
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process but have nonetheless become ubiquitous, and true
standards, which are created through a formal standardization
process with the input of many. While standards and common
formats are a benefit to a field, there can exist too much of a
good thing, in the form of excess and uncoordinated standards
or formats, which can cause confusion in the community
and extra work for software developers, who must attempt to
support extra formats.
In an attempt to coordinate data standards for the burgeoning
field of proteomics, the Human Proteome Organization (HUPO)
formed the Proteomics Standards Initiative (PSI) in 2002. The PSI
immediately began work to develop standard formats to encode
the output of mass spectrometers and the output of the subse-
quent informatics analysis. It also began to develop a minimum
information guideline to describe what information should be
provided when making MS proteomics data public.
MS proteomics has become the most widely used technique
for detecting and quantifying the abundance of multiple pro-
teins in complex samples. The basic workflow is to extract
proteins from a (potentially) complex biological sample, digest
the proteins into peptides with an enzyme (usually trypsin),
fractionate the sample to reduce complexity, and separate the
peptides in each fraction via liquid chromatography so that only
a few peptides are ionized and introduced into the mass spec-
trometer at a time. The instrument acquires a mass spectrum
to determine the mass-to-charge ratio (m/z) of all ions entering
the instrument at each time point. In many workflows, 1 or
more of these ions are isolated by the instrument, fragmented
in a collision cell, and then analyzed to yield a fragmentation
spectrum of just the isolated species. The resulting mass spec-
tra (or the chromatograms in some workflows) must then
undergo extensive informatics analysis via sophisticated algo-
rithms to yield protein identifications and quantitative abundance
measures.6 Many variations on this theme exist, limited only by
the continually advancing technology of mass spectrometry (MS)
instruments and the creativity of scientists and software devel-
opers to analyze the complex data into usable results.
Since there are hundreds of software tools,7,8 both com-
mercial and free, that are routinely used to process the data
being generated by instruments of many different types, of-
fered by half a dozen major manufacturers, the field of MS pro-
teomics must have well-defined standards if these tools are to
interoperate and the field is to advance rapidly. The PSI has
taken a very active role in defining standards for MS proteo-
mics and molecular interaction data over the past dozen years,
serving not only to define the standards used by many of the
software tools in the field but also to bring together the soft-
ware developers so that they exchange ideas and consider in-
teroperability issues more readily. Although the most active
members of the PSI have changed considerably over the past
dozen years, the group has successfully developed many influ-
ential standards that have enabled the interoperability of many
software tools and resources.
In the field of molecular interactions, the work of the PSI
has mainly centered on standardizing the download format of
the many protein interaction databases that currently exist
such as IntAct,9 Molecular INTeraction (MINT),9 and Database
of Interacting Proteins (DIP).10 Standardized data have allowed
the user to merge data from multiple resources relatively easily
and enabled the development of visualization and analysis tools
that operate over datasets derived from many disparate sour-
ces.11,12 For example, the user may assemble an integrated hu-
man interactome and perform sophisticated network analyses of
clinical proteomic data using packages such as the Cytoscape
data integration, analysis, and visualization package.13
We describe the methods that the PSI has employed to cre-
ate its standards, summarize the results of the PSI, discuss the
lessons learned from the PSI’s evolution, and describe future
directions and synergies for the group. This article is distin-
guished from other PSI publications in that it gives a complete
perspective on the methodologies of the PSI, its past successes
and future challenges, whereas previous publications have
described individual standards, resources, or workshops.
METHODS
Organizational Structure
The PSI has 5 categories of deliverables that have guided the
group. These are minimum information guidelines, data for-
mats, controlled vocabularies (CVs), resources and software
tools, and dissemination activities. The minimum information
guidelines are developed in broad discussions with many re-
searchers in the field. The data formats are developed primarily
by bioinformaticians to support tools but are guided signifi-
cantly by the minimum information guidelines to ensure that
the formats can encode all the specified information and more.
The CVs are developed specifically to support the formats so
that a wide variety of concepts can be encoded in flexible for-
mats using the same vocabulary. The resources and tools are
created not just by those actively participating in the PSI but
also by other developers willing to support the community-
developed standards. Finally, the members of the PSI foster
many activities to inform the community on the products of the
PSI and how they can make data analysis and sharing easier
for everyone. Each of these categories will be discussed in
more detail in the Results section below. The PSI has a leader-
ship team, the steering committee, that guides the activities
of the group. There is a single chair, assisted by 2 co-chairs.
The steering committee is then completed with 1 or 2 mem-
bers each that fulfill the roles of editor, secretary, and primary
domain coordinators for minimum reporting requirements, CVs,
and website content. The PSI is further organized into working
groups that produce the deliverables in several different cate-
gories of proteomics data. Current workings groups (WGs) are
the MS Standards WG, Proteomics Informatics WG, Molecular
Interactions WG, Protein Modifications WG, and Protein
Separation WG. Each WG has members who fill the same roles
as listed above for the steering committee (chair, co-chair, edi-
tor, etc). For an updated list of the people fulfilling the different
roles, see http://www.psidev.info/roles.
Most of the participants in the PSI are academic researchers
and bioinformatics software developers. However, a key com-
ponent for the PSI has been the involvement of instrument
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vendors, commercial software vendors, and journal editors.
The instrument vendors have an interest in ensuring that data
from their machines are compatible with a wide variety of soft-
ware. Commercial software vendors also seek the broadest
application of their software, and open formats reduce the
number of formats they must support in order to make their
software attractive to most users. Finally, the journal editors
have an interest in making the data that support the studies
they publish as openly accessible as possible, and this is
greatly facilitated by minimum information guidelines, open
data format standards, and the many tools that support them.
This helps reviewers to spot-check the data supporting claims
made in the manuscript and fosters reuse of published data,
which yields greater citations to the original publications. Senior
editors are typically present at PSI workshops, and the PSI has
hosted several smaller workshops specifically to gather input on
the PSI guidelines. There is no formal membership process for
participants, and therefore the total size of the PSI is uncertain.
However, several hundred workers have contributed to the PSI
over the past dozen years. The current count of the union of vari-
ous active PSI email distribution lists is over 250 members.
The PSI website (http://www.psidev.info) provides extensive
information on all of the activities of the PSI, including informa-
tion about the leadership, upcoming events, and working
groups. The most extensive aspect of the website is to provide
information and documentation for the products of the PSI.
Most of the formats and products of the PSI are published in
journal articles, but only a limited amount of information can
be provided in journal articles. Accompanying each article are
extensive documentation and guidance for using these prod-
ucts in the form of full specification documents, detailed exam-
ples, online documentation, and example files and discussion
lists that document the ongoing questions, answers, and dis-
cussions that took place during and after development of the
standards. Maintenance of a website to keep the information
fresh is always a challenge, but several members within the
PSI are tasked with this effort.
Organizational Processes
One of the main driving forces behind the successes of the PSI
has been the periodic multiday workshops. In the early years of
the PSI, they occurred twice per year, but as our experience
and communication has evolved, these are now held once per
year in the spring. These workshops are multiday events with
several goals. The main goal is to get the most active members
together to meet face to face and discuss the most important
open issues and, most importantly, arrive at decisions. Perhaps
the greatest challenge of standards development is that there
is often more than one way that information could be encoded
or described, with different participants promoting different
approaches. In the end, the formats should allow just a single
way to do it; thus, consensus must be achieved after consider-
ing the options. This is most easily done face to face. Further
goals of the workshops are to bring new participants into the
PSI. In an attempt to foster more local participation, the work-
shops are typically held in different parts of the world in
different years. Ideally, some of these local participants are
then motivated to begin long-term participation in the PSI.
Finally, the workshops also serve to educate those not yet fa-
miliar with the work of the PSI and those struggling to imple-
ment the standards in their own software or workflows. Easy
access to many of the developers of the standards and their
own software tools can be very beneficial for such participants.
In all, the workshops achieve several goals each year, and a
conference report has been published for each of them.14–21
However, most of the progress on standards cannot happen
in a few short days every year. Once the decisions are made,
there is significant additional work that needs to be done by
individuals, with the results to be validated by the group, in-
cluding documentation work, software development, and gen-
eration of examples. Ongoing communication amongst the
working groups is achieved via scheduled telephone confer-
ences to review progress and action items and spur continued
development. In some cases, special smaller workshops are
called to bring together the main contributors to 1 specific sub-
topic in an effort to push forward the completion of a standard.
In addition, the PSI typically hosts a special session at the
HUPO World Congress every year (usually held in September or
October). This session serves to promote the PSI by presenting
to a larger audience the progress and plans of the PSI and
fostering discussion among session participants who do not
frequently participate in other PSI events.
The 2 primary factors that set the standards developed by
the PSI apart from other formats in use are the many view-
points that go into the development and the official process by
which the end product is approved as a standard. The mecha-
nism by which standards are approved by the PSI is called the
Document Process. For each new standard, a formal specifica-
tion document is prepared along with a minimum of 3 example
files. The document and examples are submitted to the PSI
Editor. The editor checks that the submission is suitable and
then passes it to the steering committee for an initial review.
After the steering committee review, any requested changes
are made. Following this, the editor seeks peer reviewers from
the community to review the standard as they would a journal
article, after which the submitters address the reviewers’
comments. Finally, there is an open community review period,
during which the draft is well advertised and anyone in the
community is encouraged to provide feedback. At the end
of this process, after all feedback has been addressed (usually
after a few iterations), the specification is approved and it be-
comes an official standard of the PSI. This process is described
in detail by Vizcaı´no et al.22 In some cases, this process is per-
formed in parallel with the review of a manuscript that is sub-
mitted to a journal. This process ensures that all products of
the PSI are well reviewed and reflect the best wisdom of many
in the community.
In addition to creating new standards, an important ongoing
role for the PSI is to maintain its existing standards so they
remain applicable for new workflows, applications, and tech-
nologies. The PSI remains committed to maintaining its stan-
dards so that they can continue to be used for their original
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purpose and can be extended to new techniques as appropri-
ate. It is not uncommon for developers of new techniques
to hack in changes to existing formats or invent their own for-
mats if the currently available formats appear to be deficient
for supporting the technique. However, this then hinders the
adoption of the new technique, since existing software and
tools cannot interoperate with the ad hoc formats. As such, the
PSI periodically updates the formats to properly handle new
techniques, and some of these updates are also published in
scientific journals. In most cases, efforts are made to leave
the schema unchanged and support the new information via
new CV terms. When the necessary changes are too extensive
for simple CV additions, then the schema version is updated
and a revised specification document is produced and submit-




The PSI has developed several minimum information guidelines
in the past dozen years. They were initially modeled after
the successful Minimum Information About a Microarray
Experiment guidelines.23 Our goal has been to define the mini-
mum amount of information needed to understand how a study
was executed and reproduce it if needed. There is a strong ten-
dency when many PSI participants collaborate on this process
to identify many pieces of information that would be beneficial
in some circumstances to know, and it becomes difficult to
winnow down all the suggestions to a set that is truly minimal
and not overly burdensome. It is important to highlight that
in its minimum information guidelines, the PSI has never tried
to stipulate how any experiment should be done but rather just
require full disclosure of what was done. For example, there
is no language that specifies how many replicates must be per-
formed or what false discovery rate threshold to apply but
rather just how many replicates were performed and what
threshold was applied and the method used so that reviewers
or receivers of data may then better judge if the quality is
sufficient.
The Minimum Information About a Proteomics Experiment
(MIAPE) guideline was first developed by the PSI in 2006.24
It was designed to be modular in structure so that the many
possible facets of varied and complex proteomics workflows
could be captured in different modules.25 The original paper24
describes the general philosophy and structure of the modules.
Collectively, the modules provide guidelines for such informa-
tion as experimental design, hardware specifications, instru-
ment parameters, software versions and parameters, and
analysis choices. MIAPE-CC26 describes the details of column
chromatography. MIAPE-GE and MIAPE-GI describe the minimal
reporting requirements for running gel electrophoresis and gel
electrophoresis image analysis, respectively.27 MIAPE-MS28
describes the minimum information for running the mass spec-
trometer and generation of the raw data. The MIAPE-MSI29
module describes the information needed for the complex
informatics workflow used to analyze the mass spectra. The
most recent one is the MIAPE-Quant30 module, which de-
scribes all the aspects of the quantitative part of a study, from
labeling chemistry to informatics analysis. Although the multi-
plicity of these modules adds complexity, it has the advantage
that only the modules that are applicable need be selected.
A few of these guidelines have been updated since the original
versions were published.
The MIAPE guidelines have been implemented in the
ProteoRed tools31 but not in most other tools in a complete
manner, partly due to the complexity in capturing all these
metadata. In many cases, the information is being captured in
the manuscript describing a dataset but is not yet encoded in a
parsable form. The PSI formats do support the encoding of the
minimum information in the formats but do not yet require it.
In some cases, the official validation software for a format
is able to check that MIAPE guidelines have been met, eg,
mzIdentML.32 In some cases, journals have developed their
own guidelines,2,33 which tend to also require minimum-quality
criteria in an effort to promote high-quality results and mini-
mize the publication of false positives.
The PSI has also developed the Minimum Information about
a Molecular Interactions Experiment guidelines,34 primarily
aimed at improving the quality of experimental detail supplied
by authors in manuscripts and to encourage the deposition of
data into databases as part of the publication process. In prac-
tice, this has become a recognized descriptor for the amount of
information supplied by many protein interaction databases.
Related standards, detailing the information required to de-
scribe a protein affinity reagent (MIAPAR35) or drug-like mole-
cules used in drug-target studies (Minimum Information About
a Bioactive Entity36), were subsequently published by this
group.
Standard Formats
The 2 broad types of standard formats from the PSI are com-
plex formats encoded in Extensible Markup Language (XML)
and simplified summary formats encoded in tab-separated-
value tabular formats. The XML formats aim to encode nearly
complete data and metadata in a flexible fashion using a CV so
that new technologies and workflows can be supported via
new CV terms without a change in the XML schema. This heavy
use of CV terms provides the great benefit of flexibility
but comes at a cost of inflated file sizes and risk of different
“dialects”—that is, different possibilities of encoding the same
information. In this subsection, we will provide a brief history of
the evolution of the PSI development process and an overview
of the formats that the PSI has produced.
At the beginning of the PSI, it was well known that an open
vendor-neutral format for storing the output of mass spectrom-
eters was needed. Although simple text file formats for MS2
(fragmentation) spectra were numerous and common, attempts
to write quantification software that needed access to the MS1
scans were severely hindered by a lack of a common open for-
mat. The PSI began development of such a format, but due to
general inexperience with developing complex XML formats
and many varied opinions, progress was slow. At the Institute
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for Systems Biology (ISB, Seattle, Washington), lack of an open
format for all output of a mass spectrometer seemed so acute
that researchers there developed their own format, mzXML.37
Since the format needed only to meet ISB’s needs, the format
was simpler and was completed far more quickly than the
PSI’s mzData effort. The mzData was eventually finished and
released but not before mzXML had become widely used by
many pieces of software.
It was then widely recognized that having 2 different
XML-based formats for the same data, output of mass spec-
trometers, was also a hindrance. There was confusion in the
community about which format to use. Developers needed to
choose which format to use or expend extra effort to support
both. Therefore, at the 2006-PSI spring workshop, the devel-
opers of PSI’s mzData and developers of ISB’s mzXML, along
with instrument and software vendor developers, set out to
create a new format that brought together all the best aspects
of the 2 formats.38 The resulting mzML format39 was finished
and released in 2008. It was regarded widely as a significant
improvement over the 2 precursor formats. This format is now
widely used and quite stable, although use of mzXML has still
not been fully discontinued.
The TraML format40 was developed using a similar technol-
ogy (a flexible XML format constrained heavily with CV ele-
ments) as mzML. However, where mzML is designed for mass
spectrometer output, TraML is designed for mass spectrometer
target input. For data-dependent acquisition modes, the instru-
ment itself decides which ions to select for fragmentation.
However, for several data-independent acquisition (DIA) modes
such as selected reaction monitoring (SRM) and inclusion-list
based workflows, the instrument is given a list of targets for
which data should be acquired. TraML is able to encode these
inputs for mass spectrometers, both inclusion lists and SRM
transition lists. TraML can optionally also encode extensive
metadata on the lists to indicate provenance and other instru-
ment optimizations for individual elements in the list.
While the mzML format was designed to encode the mass
spectra produced by all types of instruments used in the field,
it was explicitly not designed to capture any downstream
interpretation of the spectra. The PSI has designed a pair of
XML formats to capture this downstream processing. The
mzIdentML format41 was released in 2011 and encodes the re-
sults of software that identifies the peptide ions thought to be
represented by each spectrum as well as statistical validation
of those putative identifications. In addition, it can capture the
protein identifications derived from those detected peptides, for
which guidelines have recently been updated and improved.42
The mzQuantML format,43 released in 2013, was designed to
encode the quantitative component of an experiment if it was
performed. The mzQuantML format is very flexible and can en-
code all types of quantitation results, including those from iso-
topic labeling, isobaric labeling, label-free intensity-based
quantitation, spectral counting, and SRM/DIA quantitation.
Although these 2 components were together in a single format
in early design, it was realized that the scope was too large
and progress would be better with 2 separate formats.
These 2 XML-based formats can very flexibly capture the
results of many diverse workflows along with rich metadata on
how the results were obtained. The downside is the significant
complexity in reading and writing these formats. It has become
common to export the highest-level results from these formats
into simple text files that can be easily ingested into tools such
as MS Excel (Microsoft, Redmond, Washington) and the pro-
gramming language R44 for further analysis. To meet this need,
the PSI recently developed the mzTab format,45 a tab-delimited
format that can encode the highest-level results from both
mzIdentML and mzQuantML into a single file. There were mis-
givings that providing this simpler format would discourage
the usage of the more complete XML formats. In the end, it
seemed better to standardize what seemed like an inevitable
use case rather than withhold such a format in an effort to pro-
mote mzIdentML and mzQuantML.
As described above, another major product of the PSI has
been the development of formats to support the exchange
of molecular interactions data. The PSI-MI XML format12 has
evolved significantly over the past 10 years to capture rich in-
formation about interactions between molecules of all different
types, including metabolites, DNA, proteins, and protein com-
plexes. As with other PSI formats, it has become quite complex
in the data it is able to encode, and a simpler tab-separated
format called MITAB35 has been developed to support use
cases where simplified metadata is sufficient. Due to user de-
mand, this now exists in 3 versions (MITAB 2.5, 2.6, 2.7) with
progressively more columns supplying additional information
about the interaction being studied.36
The PSI has developed some additional formats to capture
information about specific aspects of some proteomics work-
flows that cannot be captured in the above formats. The GelML
format46 encodes information about the detection, characteri-
zation, and quantification of gel spots and bands prior to exci-
sion and analysis. The spML format captures information about
molecule separation steps, primarily the separation of peptides
via column chromatography. However, it should be noted that
GelML and spML are not widely used, and their further devel-
opment has been discontinued. The qcML format47 enables the
consistent encoding and exchange of quality control metrics
derived from periodic quality control runs on an instrument;
it has not yet been approved as a PSI standard but follows the
same style and conventions as the PSI standards.
Finally, the PSI Extended FASTA Format is still in develop-
ment and aims to extend the ubiquitous FASTA format by im-
posing a specific syntax in the description field of the FASTA
format. This syntax enables the consistent parsing of metadata
for each protein such as species, names, accessions, known
sequence variants, and known post-translational modifications,
which can then be used by search engines and other down-
stream processing of the data.
Controlled Vocabularies
The PSI has developed several CVs48 primarily to correspond to
the formats. The PSI formats are generally quite flexible in the
metadata that can be encoded. Rather than having metadata
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such as instrument models, software names, and instrument
configuration modes enumerated in the XML schema, which
would then require frequent schema updates, most of the PSI
formats allow the flexible use of terms from a CV to be specified.
This allows new concepts and instances to be flexibly added
to the CV and then to documents while still ensuring that
there is only a single way to refer to a specific concept.
We make the distinction between an ontology and a CV such
that an ontology has a very carefully constructed hierarchical
structure of terms with “is a” and “part of” relationships to
join them, whereas a CV focuses on the terms and defini-
tions with less regard to their semantic relationships. The
PSI CVs are managed by committees within the PSIs and gener-
ally maintained in Open Biomedical Ontology (OBO) format,
which is easily machine-parsable and supports both CVs and
ontologies.
The PSI-MS CV49 contains most of the vocabulary terms
used by the mzML, mzIdentML, mzQuantML, mzTab, and
TraML formats, and it is also used by other databases and re-
sources such as the PRIDE database.50,51 It includes terms
for all commonly used mass spectrometers, data processing
software, and data scoring metrics that must be reported in the
various formats. This ensures that all these concepts are writ-
ten consistently and can be interpreted consistently by parsing
software. The PSI-MS CV is often updated because additions
to the CV are requested by the community on a regular basis.
The formal process followed to update the PSI-MS CV is de-
scribed in detail in Mayer et al.49 There is very little overlap
between the PSI-MS CV and other CVs or ontologies, with the
exception of the IUPAC list of MS terms,52 which is itself not
accession number based in a manner that is easily parsed by
software. It is rather a wiki-based list of terms and definitions,
and where there is overlap, we have attempted to synchronize
the terms and definitions so they are fully compatible.
The PSI-MI CV contains the many terms that are required to
encode molecular interactions in the PSI-MI XML and MITAB
formats. These terms pertain only to concepts and resources
relevant to molecular interactions and do not overlap with
PSI-MS terms. Additionally, PSI-MOD53 is a well-structured
ontology of protein, peptide, and amino acid modifications,
both natural and artefactual, and is used by both MS and MI
data resources and increasingly by other protein-centric data
resources. Several other minor CVs are in use by minor for-
mats; details may be found at the PSI website.
Databases and Tools
The development and use of such standard formats, minimum
information guidelines, and CVs can have a tremendously
beneficial effect on the advancement of a field. However, the
adoption of these standards is directly dependent on the quality
of software that implements these standards. If high-quality
and easy-to-use software enables the use of the standards, the
benefit of standards is realized. If there is no such software,
then the standards will be largely ignored and users will seek
easier paths for processing their data. For this reason, the
PSI has spent considerable effort developing and promoting
the development of such software that implements the PSI
standards.
Open-source software Application Programming Interfaces
(APIs) in Java have been developed for most of the data stan-
dards. This is essential to promote adoption and to provide
developers to include support for the standards in tools.
These software libraries provide reading/writing functionality
and other extra features. They are jmzML,54 jTraml,55
jmzIdentML,56 jmzQuantML,57 mzidLibrary,32 and jmzTab.58
Many open-source software tools implement the standards.
Some of them were developed in Java making use of these
libraries, but other programming languages have also been
used such as Python or C.59
Perhaps the most difficult hurdle is the conversion of propri-
etary vendor binary formats to open standards. Initial attempts
to reverse-engineer the vendor formats proved difficult but pos-
sible.37 However, as the vendors changed their formats to sup-
port new instrumentation, it became increasingly difficult to
maintain the reverse-engineered parsing. Instead, the success-
ful paradigm was to work with the vendors to produce a con-
sistent API in the form of dynamic link libraries (DLLs) to
access the data in the binary formats as implemented in
ProteoWizard.60,61 This enabled a system of open-source li-
braries that could uniformly access data in the vendor binary
formats, allowing direct access to data in the files, either for di-
rect use by software or for conversion to an open standard for-
mat.62 Although direct access is seemingly preferable, in
reality, the vendors have only provided Microsoft Windows-
based (Microsoft, Redmond, Washington) DLLs, and thus direct
access software must run on Windows or potentially Windows
emulators. If the conversion strategy is used, then only the con-
version must happen on the Windows-based computer, but all
downstream processing may occur under other operating sys-
tems such as Linux or OS X.
In the context of MS proteomics databases, the
ProteomeXchange consortium (http://www.proteomexchange.
org)63 of proteomics resources has been recently established
to develop standard submission procedures and dissemination
pipelines of proteomics data in public databases, promoting
data sharing practices in the field. At the moment of writing,
it includes the resources PRIDE, PeptideAtlas (including
PASSEL),64,65 and MassIVE (http://proteomics.ucsd.edu/
ProteoSAFe/datasets.jsp). The consortium started as 1 output
of the PSI group, and as such, one of the objectives of the consor-
tium is to promote the use of PSI standards for storing the data.
In the field of molecular interaction databases, all major
resources now make downloads available in the PSI-MI for-
mats. These include primarily protein-protein databases such
as IntAct,9 MINT,9 and DIP;10 drug-target databases such as
ChEMBL66 and DrugBank;67 and pathway resources like
Reactome.68 The IntAct database has also shown the format to
handle more complex data types such as transcription factor-
transcribed gene associations and the encyclopedic description
of protein complexes. The use of shared data formats and CV
terms has resulted in annotation/data gathering procedures
becoming increasingly standardized across the different data
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resources, improving the user experience and making data in-
tegration much easier. Common standards have also enabled
web services to be built across collaborating data resources,
and a single query using the PSICQUIC query interface69
searches data in 31 different databases before presenting the
user with a single collated response. The closer working rela-
tionship between many of the interaction databases resulted in
the formation of the International Molecular Exchange (IMEx)
Consortium70 to promote higher standards in data curation and
to gather in the vast wealth of interaction information scattered
across the scientific literature to be managed in a collaborative,
nonredundant manner.
Dissemination
While the creation of high-quality software tools has been a
major factor in adoption of the PSI standards, other forms of
dissemination have also played a key role. Although the activi-
ties of the PSI are largely led and implemented by academic re-
searchers and members of their labs, vendor participation has
been an important component. Involving the vendors in the
design phases and the implementations of the standards en-
courages them to implement support for the standards in their
own software, which leads to greater interoperability between
commercial and open-source software as well as greater use
of the standards in general.
Journal editor participation has been a key component of the
dissemination efforts of the PSI. Not only have the editors been
active participants in the development of minimum information
guidelines, but they have also encouraged the formal publication
of the standards and the tools that implement them in journal ar-
ticles. In fact, there have been 10 or more journal articles pub-
lished by the PSI each year over the past 5 years (for a
comprehensive list see the PSI profile at Google Scholar at http://
scholar.google.com/citations?hl¼en&user¼oNoChlcAAAAJ).
The PSI regularly hosts a workshop at each annual HUPO
World Congress. These workshops typically consist of a few
short presentations on the recent progress and ongoing efforts
of the PSI followed by an opportunity for discussion and feed-
back with the audience. Other dissemination activities include
hands-on training courses, in which the use of data standards
is taught to mainly PhD students and postdocs, as part of
broader courses on Proteomics Informatics or Network and
Pathway analysis techniques.
The PSI has also engaged in efforts to spread its standards
and methods for creating them to other disciplines. For exam-
ple, the PSI has recently reached out to the metabolomics
community. The mzML format is now being used in the metab-
olomics field after minor enhancements. The tab-delimited for-
mat mzTab supports metabolomics results in its first stable
version. In addition, a group of stakeholders is currently work-
ing towards improving metabolomics data representation in
mzTab (foreseen for the next version 1.1). The Coordination Of
Standards In Metabolomics71 group is developing the nmrML
format for storing the output of nuclear magnetic resonance
(NMR) instruments following the methodology of the PSI.
Similarly, the Molecular Interaction group has influenced the
development of standards in the fields of protein affinity re-
agent production and of bioactive molecules such as drugs,
herbicides, pesticides, and nutrachemicals.
All of the products of the PSI, including guidelines, format
specifications, schemas, examples files, etc, may be examined
and downloaded at the PSI website primarily. Some products
are also hosted at central clearinghouses for similar products.
For example, the PSI CVs are also distributed at BioPortal,72 the
OBO Foundry,73 and the Ontology Lookup Service.74
DISCUSSION
Minimum Information Guidelines
The minimum information guidelines developed by the PSI
(described above) have been useful but not adopted as widely
as originally hoped. A few of the proteomics journals mention
MIAPE as a recommendation, but none requires it. The journal
Molecular and Cellular Proteomics (MCP) has developed its
own set of guidelines.33 These guidelines are similar in many
ways but also subtly different in aims. While the MIAPE guide-
lines are designed to describe what was done without imposing
restrictions on minimal-quality metrics, the MCP guidelines
extend further into providing minimal-quality guidelines and re-
quirements for easily viewable spectra in cases where protein
or post-translational modification detection evidence is not
solid, in an effort to reduce the publication of spurious results.
The MIAPE guidelines have been used as a guide for the devel-
opment of software applications31 but is not universally ap-
plied. In some cases, it is viewed as being too demanding, but
its low adoption mostly has been due to the lack of elegant
software to make it easy for users to capture, manipulate, and
edit metadata conforming to the MIAPE guidelines. If many
more software applications would implement it in a way that is
easy for users, adoption would increase significantly. When
such software applications become widely available, the jour-
nals would likely feel more confident about making MIAPE
compliance a requirement.
Formats
The primary formats of the PSI have all been implemented
in XML. The main reasons are that there are many tools in all
languages to read, write, and validate XML, and that XML is
text-based and thus human readable. This human readability
has many benefits. It facilitates the development of the formats
as the example data files can be easily viewed and discussed.
It is easy for developers to resolve parsing problems by exam-
ining the files with a text viewer to determine what parts of
the file are causing unexpected problems. In the case of minor
errors or corruptions, a simple text editor can often be used to
correct the problem and render the file readable once again.
Finally, since the format is text-based and there are many open
source XML parsers, these formats will remain readable in per-
petuity. The primary drawback is that XML files are inefficient
in terms of file size. However, disk space is relatively cheap
compared with developer time and human effort; thus, this
seems like a small cost. Further, these formats can be com-
pressed with zlib, for example, although this renders some
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of the benefits described above somewhat tenuous. Other tech-
nologies similar to XML such as Resource Description
Framework (RDF) were considered early on during the develop-
ment of mzML, but these were dismissed in favor of XML pri-
marily on account of unfamiliarity with RDF to the available
developers, RDF’s event greater verbosity, and RDF’s apparent
better suitability to metadata than raw data.
The landscape of MS proteomics is changing rapidly; there-
fore, it is necessary that the PSI formats are able to adapt to
these changes. One option is to maintain a tightly controlled
schema and update the schema frequently as new techniques,
instruments, or workflows become available. However, there
was great desire, especially from commercial companies, for
the schemas to remain stable for a long time. The solution that
was agreed upon was to create stable schemas that could be
maintained for long periods of time but allow flexibility in the
CV terms that could be used in the document. Thus, the format
dictates where CV terms may be placed, but which CV terms
are used can be flexible and can be adapted over time. As new
techniques, instruments, and workflows become available,
they can be described in the CV and then immediately used in
documents. Some software that compiles a specific version of
the CV into the code would need to be recompiled, but software
that dynamically uses the latest CV may be able to make rea-
sonable use of new terms without any changes. Validator pro-
grams for the PSI formats ensure that the CV terms are used in
proper locations inside the data files.
In recent years, the first tab-delimited files have been devel-
oped. The motivation behind the development of formats like
mzTab and MITAB was that tab-delimited formats had been previ-
ously successfully applied in other bioinformatics fields (for in-
stance, the MAGE-TAB75 format in the microarray community),
and it was perceived as a way to gain users (since some bioinfor-
maticians prefer to implement tab-delimited file formats and are
not so motivated to do it with XML-based formats) and to facilitate
the reuse of proteomics data in other biological fields via easy
export into MS Excel (Microsoft, Redmond, Washington) or R.
It has been commented that the sheer number of different
formats produced by the PSI is confusing and that fewer formats
would be less confusing. Current development has generally fol-
lowed the paradigm of 1 format per data type. Since there are
many different data types, many formats have been produced.
However, since most of the XML formats follow a similar design
methodology, there would be no major hurdles to combining the
schemas to produce a format that could contain several data
types. However, opinions vary on whether this would be benefi-
cial or not, and there is no clear best path forward. However,
since file sizes are already a problem in many cases, random ac-
cess in XML files to pull out the needed information quickly is
awkward, and all software would have to be adapted to read yet
another format; creating a single format with many components
for different data types seems impractical.
Funding of activities
For the first 8 years of the operation of the PSI, there was es-
sentially no stable funding for PSI development. All leaders
and participants were contributing their time to the perceived
laudable goals of the PSI. Sometimes these goals were
well aligned with individual grants that paid the contributors.
The workshops were funded by contributions from the vendors
and other commercial companies that saw it beneficial to fund
these workshops, both from the standpoint of having a “seat
at the table” where the standards were developed and as a
marketing benefit in general. In 2006, the European Union
(EU)–funded Proteomics Data Collection Consortium began par-
tially funding personnel to work on PSI standards. Starting in
2009, first the PSIMEx and then the ProteomeXchange FP7 EU
coordination grants were funded, which explicitly included
funding for personnel for software and standards development
as well as funding for the workshops and other coordination
activities. In 2013, as the ProteomeXchange grant was ending,
the new UK Biotechnology and Biological Sciences Research
Council (BBSRC)-funded “PROCESS” grant was obtained to
continue funding some PSI activities. This was followed in 2014
by the “MIDAS” grant, also funded by the BBSRC, to support
molecular interaction activities. The main conclusion is that while
it has been possible to obtain funding for workshops from com-
mercial companies with an interest in the formation of robust
standards, funding from granting agencies for personnel and
workshops has been crucial for the progress of the PSI.
Interactions with other efforts
The interactions between the PSI and other consortia have pro-
vided great synergies and benefits to all parties. The PSI has
been most closely working with the ProteomeXchange63 and
IMEx consortia, since many of the most active PSI participants
are also key personnel within 1 of these 2 consortia. The con-
sortia are better able to accept and manage data because
of the existence of standard formats, and the PSI benefits from
increased participation and adoption of the standards it produ-
ces. Similarly, synergies between the PSI and the Proteome
Project (HPP)76,77 have benefited both groups. The HPP has
committed to make all data produced by participants publicly
available via public repositories using PSI formats, and the PSI
gains in visibility and adoption of its standards. Once the stan-
dards are used as part of 1 data submission or contribution to
the HPP, they are more likely to be used in other unrelated
projects as well. Several PSI formats have been adopted for
use by metabolomics data pipelines and repositories. This has
the following advantages: (1) The metabolomics community
can benefit directly from lessons learned and extensive stan-
dardization work by the PSI. (2) Software can be reused in
metabolomics contexts without major changes. (3) Data inte-
gration becomes easier when data formats are shared between
2 data types. (4) The PSI formats become more generally appli-
cable and widely used. Such interactions between the PSI and
other groups have been a general benefit to the whole field of
biomedical informatics.
Challenges for the future
Despite the many successes of the PSI, there remain many
important challenges that need to be addressed. Most of the
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original goals of the PSI have been realized. We now have a set
of stable approved standards for the major proteomics data
types. What then remains? New needs, of course, will continue
to emerge. For example, there is a growing demand for high-
quality libraries of previously identified spectra, and there is no
standard for this data type; thus, this is an obvious next step.
However, moving beyond the creation of additional data stan-
dards to meet the needs of advancing technologies, the PSI
faces additional challenges to maintain its past effectiveness.
Despite the general success in achieving reasonable consensus
and producing high-quality standards, adoption of the stan-
dards is not universal. The PSI should focus on fostering the
development of better software that makes use of the stan-
dards easier. A few journals have developed their own data
quality guidelines, and it would be beneficial for everyone if
the PSI and existing journal guidelines could be reconciled. As
discussed above, there does exist a perception by some that
the PSI has created too many, varied formats, and the commu-
nity would be better served by fewer formats that can hold
more data types.
Several of our standards are applicable to other fields, and
it would be useful to work with other communities beyond pro-
teomics to achieve standards that can be applied to multiple
disciplines. This has the effect of simplifying data analysis
for all users. Finally, it will be a challenge to maintain healthy
participation in the PSI. In earlier years, when the need for data
standards was acutely visible, the PSI was easily able to recruit
new programmers interested in developing important stan-
dards. But now, with many prominent standards in its portfolio,
the need to join the PSI seems less compelling. Indeed, despite
a repeated message that the PSI welcomes the participation of
new members, there is a growing perception that those who
have worked on these initial standards are the PSI, and so
there seems less motivation for others to become a part of the
initiative. Meeting these challenges will be required to expand
the contributions of the PSI.
CONCLUSION
The PSI has been very productive over the past dozen years
and has helped accelerate the field of proteomics by greatly fa-
cilitating data sharing and data deposition in public data reposi-
tories. This has occurred through the coordinated development
of minimum information guidelines, standard data formats,
and, most importantly, software that implements these guide-
lines and formats. The success in proteomics is now attracting
interest in other fields such as metabolomics, which will facili-
tate the integration of metabolomics data with proteomics data
and applications to personalized medicine. Synergies with the
MIBBI project78 are creating a bridge to entry points in medical
informatics.
As technology advances over the next dozen years, the
PSI will need to adapt current standards to remain relevant to
these advances and forge new standards to enable data shar-
ing and the interoperation of different software packages.
Already, new workflows such as SWATH-MS79 and other DIA
technologies are poised to revolutionize data collection, but
analysis software for such workflows is still in its infancy and
will benefit from standard formats so that different tools are
interoperable. Further, coordination of standards with other
omics technologies via similar standards organizations will
greatly facilitate multiomic data integration.
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We wish to express our deep sorrow at the passing of Juan
Pablo Albar. Juan Pablo was a passionate contributor to HUPO
and the PSI and an esteemed colleague. He will be greatly
missed by us all. He contributed to the first submission of the
article but passed away before it could be published.
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